Page 113 - 16Neonatal Jaundice_compressed
P. 113

Neonatal jaundice





                         measurements were taken from the forehead simultaneously with blood sampling. The median
                         transcutaneous measurement was 209 micromol/litre. The BiliChek overestimated diazo serum
                         bilirubin by a mean of 34 micromol/litre  and  VITROS  serum bilirubin by a mean of
                         22 micromol/litre. There  was a  moderately  positive correlation  between transcutaneous
                         bilirubin and serum bilirubin values: diazo (r² = 0.65)  and VITROS (r² = 0.66) when bias  was
                         accounted for. [EL III]

                         Evidence summary – BiliChek
                         Evidence from good-quality studies indicates that transcutaneous bilirubin measurement from the
                         forehead using BiliChek correlates moderately well with serum bilirubin values in term and near-
                         term babies. The correlation coefficient ranged from 0.80 to 0.87. In a study in healthy preterm
                         babies it was 0.79 whereas in another study in preterm and sick term babies it was 0.88.
                         BiliChek was less accurate at bilirubin levels greater than 250 micromol/litre. Results from two
                         studies have reported an increase in the mean difference between serum bilirubin and BiliChek
                         readings  with  a  rise  in  bilirubin  levels.  One  study  found  the  BiliChek  underestimated  serum
                         bilirubin in healthy  term and near-term  babies while  two studies reported overestimation in
                         healthy term and preterm babies. Altough there were differences in the populations studied, in
                         threshold cut-off values  of transcutaneous bilirubin and  in  the levels of laboratory serum
                         bilirubin used as the reference test, the sensitivity of  BiliChek to detect  bilirubin levels  was
                         generally reported to be high, with variable results for the specificity. In the study on African
                         babies, BiliChek readings showed a reasonable correlation with serum bilirubin values but the
                         difference  between transcutaneous bilirubin and  serum bilirubin was greatest in babies with
                         darker skin tones.

                         GDG translation from evidence – BiliChek
                         High-quality  research  suggests  that  forehead  or  sternum  measurement  of  transcutaneous
                         bilirubin by BiliChek is more accurate than visual inspection when used to assess the degree of
                         jaundice in term and near-term babies with a range of skin tones.
                         Good-quality studies of BiliChek measurement in preterm babies show a significantly positive
                         correlation with serum bilirubin but there are no studies that report the use of the BiliChek in
                         babies  with  gestational  age  less  than  30 weeks.  The  GDG  considered  that,  given  the  lack  of
                         evidence regarding babies of less than 30 weeks of gestation, they could not recommend the
                         use of the BiliChek in very preterm babies.
                         BiliChek is less accurate at higher levels of bilirubin and in babies with dark skin tones.

                         Recommendations
                         See the end of Section 5.2.

                         Cost-effectiveness evidence for transcutaneous bilirubinometers
                         Alternative testing strategies for hyperbilirubinaemia was identified by the GDG as a priority for
                         an economic analysis. The results are summarised below; further details are available in
                         Appendix C.

                         The GDG considered that there were two alternative testing strategies to ‘current practice’ in the
                         NHS. These two strategies were to either perform a serum bilirubin on all visually jaundiced
                         babies or undertake a transcutaneous bilirubin measurement on all visually jaundiced babies,
                         with a serum bilirubin measurement on those with transcutaneous bilirubin estimations above a
                         certain threshold. They judged that,  under their recommended thresholds for  treatment  (a
                         relatively high threshold) and further monitoring (a relatively low threshold), either alternative
                         would  be  equally  effective  at  preventing  cases  of  kernicterus.  Therefore,  a  cost-minimisation
                         analysis was undertaken to compare these alternatives. There is insufficient clinical evidence to
                         determine whether more intensive testing for hyperbilirubinaemia using one of these two
                         strategies would be more cost-effective than ‘current practice’, in which visual examination is
                         often used to determine the severity of hyperbilirubinaemia,  with less than 10% of visually
                         jaundiced babies having a serum bilirubin. However, there is very good evidence to show that
                         visual examination is not reliable in assessing the degree of hyperbilirubinaemia in a jaundiced

              84
   108   109   110   111   112   113   114   115   116   117   118